A pro-vaccine physician went to the anti-vaccine movement’s biggest gathering. He warns that public health must learn what it ...
Designed by clinicians for clinicians, BOS improves clinical outcomes, financial performance, and value-based care results. LOS ANGELES, CA / ACCESS Newswire / November 11, 2025 / Precise Behavioral, ...
The company scans entire proteins with CRISPR to find functional vulnerabilities, then hunts for molecules that exploit them ...
As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...
Ultimately, achieving Universal Health Care will depend on our collective ability to invest more where it matters, procure ...
RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) wishes to supplement the information contained in its management ...
As the prospect of import tariffs and drug price reform marshals billions of biopharma investment dollars into the U.S., the ...
Eli Lilly and Novo are preparing to announce new drug pricing deals with the White House, including for their blockbuster ...
FillPoint Health, a Lyceum Health company and URAC/ACHC-accredited specialty pharmacy and MSO, announced today a strategic partnership with Noble, an Aptar Pharma company and global leader in drug ...
PhaseV, a leader in AI/ML for clinical development, today announced it has received three significant 2025 industry honors, highlighting the growing market traction and adoption of its platform for ...
Nasus Pharma (NSRX) announced that it recently received a No-Objection Letter from Health Canada, the country’s primary regulatory authority for ...
Positive Regulatory Response Marks Important Milestone for NS002 Development ProgramTEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback